Lung Cancer Essay

* Bronchoscopy - a thin flexible tube is passed gently through your nose or mouth and into the lung airways. Photographs and cell samples are then taken. This may be done under local anaesthetic as an outpatient, or under sedation or a general anaesthetic.

What are lung cancers? Lung cancers are the abnormal cells which grow in uncontrolled manner in one or both lungs. They do not function as normal lung cells and do not develop into healthy lung tissue. The abnormal cells can grow, form tumours and interfere with the normal functions of the lung (Lungcancer.org, 2015). Lung cancers can be divided into two major types, namely non-small cell lung cancers (NSCLC) and small cell lung cancers (SCLC). NSCLC can be further classified into three main subtypes, namely adenocarcinoma, squamous-cell carcinoma and large-cell carcinoma (Longo & Harrison, 2012). Lung cancers can be diagnosed by chest X-ray, computerised tomography (CT) scan, positron emission tomography-computerised tomography (PET-CT) scan, bronchoscopy and biopsy (Nhs.uk, 2015). Unfortunately, lung cancers are often diagnosed at the later stages. This is due to the unrecognisable symptoms and warning signs at the earlier stages. NSCLC are often diagnosed at stage IV which accounts for 30-40% of cases whereas 60% of SCLC is diagnosed at stage IV. Lung cancer usually originates from the cells lining the bronchi, bronchioles and alveoli. Carcinogens especially tobacco smoke will alter the gene expression of the normal human lung cells, resulting in cell mutation. The proto-oncogenes will be converted to mutated form, oncogenes. Mutation leads to the decreased expression of the tumour suppressor genes. This results in uncontrolled cell proliferation, cell

In the past years, there has been a major paradigm shift in the management of non-small cell lung cancer also known as (NSCLC). NSCLC should now be further sub-classified by histology and driver mutation if one is known or present. Translational research results now allow such mutations to be inhibited by either receptor monoclonal antibodies (mAb) or small molecule tyrosine kinase inhibitors (TKI). Whilst empirical chemotherapy with a platinum-doublet remains the gold standard for advanced NSCLC without a known driver mutation, targeted therapy is pushing the boundary to significantly improve patient outcomes and quality of life. In this review, we will examine the major subtypes

A doctor can diagnose lung cancer through many tests. The doctor can have x-rays and CAT scans done to see what the inside of the lungs look like. By doing this that doctor is able to see what stage the cancer is in. A doctor may also do a test called a bronchoscope. This test allows the doctor to look inside the bronchial tubes and biopsy the tumor. The doctor then can take a small amount of the cells to study them to determine if the unusual cells are cancerous. If the cells turn out to be cancerous then the patient is in for many months even years of harsh treatment.

The N category describes whether or not the cancer has spread into nearby lymph nodes.

Lung Cancer, like any other type of cancer, is the uncontrollable growth of cells in the lung tissue. The main causes that contribute to lung cancer include inhaling carcinogens (basically, smoking), exposure to ionizing radiation, viral infections and even air pollution. These factors basically damage the tissues lining the bronchi in the lung, leading the cancer to develop further (Vaporciyan & Nesbitt JC, 2000). Primary lung cancers that develop in the epithelial tissues of the lung are known as carcinomas and claim the top spot in terms of leading cancer-related death causes. As of 2004, lung cancer

Lung Cancer is a disease which consists of uncontrolled cell growth in lung tissues. Lung cancer consists of two types, Non-small cell lung cancer, and small cell lung cancer. (NSCLC) is the most common type of lung cancer. The bronchi are the large air tubes leading from the trachea to the lungs that convey air to and from the lungs, and where most lung cancers begin. The body normally maintains cell growth only

Cellular / Molecular Basis: Lung cancer has two types; small cell and non small cell. The two types can be identified by their appearance when looked at with a microscope. It usually affects the cells that are lined along air passages in the lungs.

Utilize your resources such as your text and the Welch library online for UpToDate. Look at the example case for format

There are different types of lung cancers. NSCLC occurs when abnormal cells grow uncontrollably. The abnormal tissues multiply, and they form malignant tumors. The tumors can spread to other organs and tissues. Smokers have the highest rates of NSCLC. Prolonged exposure to radon can also cause NSCLC.

Although many people have heard about lung cancer, they don't know that there are two major types of lung cancer. The types of lung cancer are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). NSCLC breaks down into three different types and approximately makes up 85-90% of the cancers that patients are diagnosed with. The first type of NSCLC is adenocarcinoma. This type of cancer is usually found in smokers however it is the most common lung cancer found in nonsmokers. This cancer typically attacks younger adults and targets women. This cancer tends to develop on the outside layers of the lungs and it can be found before it spreads throughout the body. The second type of NSCLC is squamous cell carcinoma. This cancer is linked to smoking and forms in the inner airways of

The body is made up of hundreds of millions of living cells. Normal body cells grow, divide, and die in an orderly fashion. During the early years of a person’s life, normal cells divide faster to allow the person to grow. After the person becomes an adult, most cells divide only to replace worn-out or dying cells or to repair injuries. Cancer begins when cells in a part of the body start to grow out of control. There are many kinds of cancer, but they all start because of out-of-control growth of abnormal cell (American Cancer Society, 2010).

Cancer, it can affect anyone; it can affect any part of the body but what is it? Cancer results from the abnormality in the body's cells. This occurs when the cells divided and grow. Disruption in the system of the growth and division of a cell results in an uncontrolled division and proliferation of cells that form a mass which leads to cancer. The patient outcome for cancer is different for everyone, but it is also different with each type. In the respiratory department, a major type of cancer we will deal with is lung cancer. Lung cancer, however, has different types and stages, but for this paper, we are going to talk about Stage IIIA non-small cell lung cancer (NSCLC). In the article titled “Stage IIIA Non-Small Cell Lung Cancer” it states

For many years now, the fusion of a PET/CT scanner has proven to show its benefits in staging lung carcinoma, especially NSCLC. Lung cancer staging is done with the TMN staging system. The T refers to the size of the primary tumor and whether it has invaded local tissue. A few studies have shown that PET alone or CT with contrast, is not as accurate as combined PET/CT for the T staging of NSCLC (B, M, N). Pawaroo et al. showed that the PET aspect of PET/CT is useful for outlining the primary tumor volume, especially if there is atelectasis or invasion into the mediastinum. However, PET/CT is less accurate if the subtype is a bronchoalveolar adenocarcinoma (Pawaroo).

If Lung Cancer is suspected a few other tests can be used in conjunction to make a final determination of lung cancer